Skip to main content

Advertisement

Log in

A male patient who developed late-onset primary biliary cirrhosis presenting with antinuclear envelope antibodies

  • CASE REPORT
  • Published:
Modern Rheumatology

Abstract

 An 81-year-old man who had previously shown high levels of alkaline phosphatase (ALP), γ-glutamyltransferase (GTP), and total bilirubin presented with acute liver damage. He was positive for serum anti-gp210 and anti-p62 antibodies, but negative for serum antimitochondrial antibody. A liver biopsy revealed massive interstitial fibrosis and pseudolobulus, which were compatible with a diagnosis of primary biliary cirrhosis (PBC) at Scheuer's stage 4. He was given ursodeoxycolic acid at 600 mg/day. However, his condition deteriorated, and he eventually died of hepatic insufficiency in a state of malnutrition. We hypothesize that the presence of anti-gp210 and anti-p62 complex protein antibodies, rather than that of antimitochondrial antibodies, was correlated with the progression of PBC in this particular case.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Received: December 18, 2000 / Accepted: December 26, 2001

Acknowledgments We thank Dr. Eng M. Tan of the W.M. Keck Foundation, Scripps Research Institute, LaJolla, California, USA, for the determination of antilamina-associated polypeptide (LAP)-2 antibodies in the SS patient included as a control in this study. We also thank Dr. P.A. Berg of Tubingen University for the determination of anti-M4 and anti-M8 antibodies.

Correspondence to: K. Miyachi

About this article

Cite this article

Miyachi, K., Horigome, T., Matsuoka, Y. et al. A male patient who developed late-onset primary biliary cirrhosis presenting with antinuclear envelope antibodies. Mod Rheumatol 12, 0246–0249 (2002). https://doi.org/10.1007/s101650200043

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s101650200043

Navigation